Tudor Financial Inc. Buys 4,497 Shares of iShares Biotechnology ETF $IBB

Tudor Financial Inc. boosted its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 155.6% in the 4th quarter, Holdings Channel.com reports. The firm owned 7,387 shares of the financial services provider’s stock after acquiring an additional 4,497 shares during the quarter. Tudor Financial Inc.’s holdings in iShares Biotechnology ETF were worth $1,247,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Summit Financial LLC lifted its stake in iShares Biotechnology ETF by 124.0% in the 4th quarter. Summit Financial LLC now owns 40,662 shares of the financial services provider’s stock valued at $6,863,000 after purchasing an additional 22,507 shares during the last quarter. Quadrant Capital Group LLC bought a new position in iShares Biotechnology ETF in the 4th quarter valued at approximately $135,000. Laurel Oak Wealth Management LLC bought a new position in iShares Biotechnology ETF in the 4th quarter valued at approximately $254,000. FineMark National Bank & Trust lifted its stake in iShares Biotechnology ETF by 78.4% in the 4th quarter. FineMark National Bank & Trust now owns 3,158 shares of the financial services provider’s stock valued at $533,000 after purchasing an additional 1,388 shares during the last quarter. Finally, HRT Financial LP acquired a new stake in iShares Biotechnology ETF during the 4th quarter worth approximately $3,751,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.1%

NASDAQ:IBB opened at $170.66 on Friday. The firm’s 50 day simple moving average is $170.28 and its 200 day simple moving average is $170.65. iShares Biotechnology ETF has a one year low of $123.61 and a one year high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were given a $0.1218 dividend. This represents a $0.49 annualized dividend and a yield of 0.3%. The ex-dividend date was Tuesday, March 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.